Heart Disease Trial, Recruiting NCT05023785 Sponsor: University Health Network, Toronto Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT05023785
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who were diagnosed with cancer at age 39 or younger, and who are between 18 and 45 years old at the time of joining the trial
  • People who received cancer treatments known to carry risks to the heart, such as certain chemotherapy drugs (for example, anthracyclines, trastuzumab, or platinum-based medicines), radiation therapy, or certain targeted therapies
  • People who are free of cancer at the time of joining the trial
  • People who show early signs of heart stress or reduced heart function after cancer treatment — this may be detected through heart imaging tests or a blood test, even if no symptoms are present (confirm with trial site for the specific measurements that apply)

Who may not be able to join:

  • People for whom exercise is considered medically unsafe, based on established sports medicine guidelines
  • People with an untreated physical or mental health condition that would make safe participation in exercise difficult
  • People who already have a diagnosed heart or cardiovascular disease (beyond the specific type of mild heart function change described in the inclusion criteria above)
  • People who are pregnant at the time of joining the trial
  • People who are already doing more than one high-intensity exercise session per week on a regular basis
  • People who face significant practical barriers to participation, such as living too far from the trial centre, or being unable or unwilling to follow the trial's requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 416-340-5326

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 January 2024
Est. completion
1 September 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Cardiorespiratory fitness

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov